131 related articles for article (PubMed ID: 1696770)
1. Construction of an immunoradiometric assay for ovarian cancer associated antigen CA125 recognizing different antigenic determinant.
Saga T; Endo K; Nakashima T; Awaji T; Koizumi M; Kawamura Y; Watanabe Y; Konishi J; Nonogaki H; Nanbu Y
Acta Obstet Gynecol Scand; 1990; 69(2):175-81. PubMed ID: 1696770
[TBL] [Abstract][Full Text] [Related]
2. [Basic study of CA125 measurement using a newly developed "SD-8729" IRMA kit].
Yamaguchi A; Kobayashi M; Imai T; Otake H; Matsubara K; Hatori N; Tomiyoshi K; Inoue T; Endo K
Kaku Igaku; 1993 Oct; 30(10):1245-52. PubMed ID: 8264116
[TBL] [Abstract][Full Text] [Related]
3. Recognition of ovarian cancer antigen CA125 by murine monoclonal antibody produced by immunization of lung cancer cells.
Matsuoka Y; Nakashima T; Endo K; Yoshida T; Kunimatsu M; Sakahara H; Koizumi M; Nakagawa T; Yamaguchi N; Torizuka K
Cancer Res; 1987 Dec; 47(23):6335-40. PubMed ID: 3315184
[TBL] [Abstract][Full Text] [Related]
4. Clinical evaluation of new cancer-associated antigen CA125 II in epithelial ovarian cancers: comparison with CA125.
Kobayashi H; Tamura M; Satoh T; Terao T
Clin Biochem; 1993 Jun; 26(3):213-9. PubMed ID: 8330391
[TBL] [Abstract][Full Text] [Related]
5. [Basic studies of BALL ELSA CA125-II KIT for detection of serum cancer antigen 125].
Kakizaki J; Miyazaki T; Maeda T
Kaku Igaku; 1993 Jul; 30(7):807-12. PubMed ID: 8377304
[TBL] [Abstract][Full Text] [Related]
6. [The preparation and clinical use of a radioimmunoassay CA125 kit for the diagnosis of epithelial ovarian cancer].
Liu W
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1992 Dec; 14(6):469-72. PubMed ID: 1303823
[TBL] [Abstract][Full Text] [Related]
7. Daunorubicin conjugated to a monoclonal anti-CA125 antibody selectively kills human ovarian cancer cells.
Sweet F; Rosik LO; Sommers GM; Collins JL
Gynecol Oncol; 1989 Sep; 34(3):305-11. PubMed ID: 2788601
[TBL] [Abstract][Full Text] [Related]
8. Development of new immunoradiometric assay for CA 125 antigen using two monoclonal antibodies produced by immunizing lung cancer cells.
Kunimatsu M; Endo K; Nakashima T; Awaji T; Saga T; Watanabe Y; Kawamura Y; Ohta H; Koizumi M; Sakahara H
Ann Nucl Med; 1988 Nov; 2(2):73-9. PubMed ID: 3275111
[TBL] [Abstract][Full Text] [Related]
9. Characterization of CA125 glycoprotein using 3 monoclonal antibodies with different specificities.
Kobayashi F; Sagawa N; Fujii S; Mori T; Endo K
Gynecol Obstet Invest; 1994; 37(3):199-203. PubMed ID: 8005553
[TBL] [Abstract][Full Text] [Related]
10. [Heterogeneity of the CA125 antigen that coexpresses sialyl Tn and CA19-9 antigens].
Kobayashi H; Ohi H; Shinohara H; Terao T
Nihon Sanka Fujinka Gakkai Zasshi; 1993 Sep; 45(9):980-6. PubMed ID: 8371024
[TBL] [Abstract][Full Text] [Related]
11. A new CA125-like antigen (CA602) recognized by two monoclonal antibodies against a newly established ovarian clear cell carcinoma cell line (RMG-II).
Nozawa S; Yajima M; Sasaki H; Tsukazaki K; Aoki D; Sakayori M; Udagawa Y; Kobayashi T; Sato I; Furusako S
Jpn J Cancer Res; 1991 Jul; 82(7):854-61. PubMed ID: 1715339
[TBL] [Abstract][Full Text] [Related]
12. Dissociation in serum CA125 concentrations measured by different monoclonal antibodies.
Sakahara H; Kousaka T; Hattori N; Tomida K; Yao Z; Hosono M; Kobayashi H; Shirato M; Endo K; Konishi J
Gynecol Oncol; 1994 Mar; 52(3):301-5. PubMed ID: 7512519
[TBL] [Abstract][Full Text] [Related]
13. An antibody-tumor model for the targeting of CA125-producing gynecologic malignancies.
Saga T; Ishiwata I; Endo K; Sakahara H; Koizumi M; Watanabe Y; Nakai T; Hosono M; Ishikawa H; Sawada M
Jpn J Cancer Res; 1990 Nov; 81(11):1141-8. PubMed ID: 2125039
[TBL] [Abstract][Full Text] [Related]
14. [A new monoclonal antibody (SH-9) recognizes the low molecular mass of ovarian cancer antigen CA125].
Maeda H; Imai S; Morimoto J; Kiyozuka Y; Noda T; Haga S; Hiroishi S
Nihon Sanka Fujinka Gakkai Zasshi; 1990 Apr; 42(4):320-6. PubMed ID: 1694212
[TBL] [Abstract][Full Text] [Related]
15. Characterisation and clinical usefulness of CA130 antigen recognised by monoclonal antibodies, 130-22 and 145-9, in ovarian cancers.
Kobayashi H; Ohi H; Fujii T; Terao T
Br J Cancer; 1993 Feb; 67(2):237-43. PubMed ID: 7679280
[TBL] [Abstract][Full Text] [Related]
16. [Basic and clinical studies of serum CA195 antigen assay with "BL-CA195" kit].
Kobayashi M; Yamaguchi A; Imai T; Otake H; Igarashi H; Hatori N; Tomiyoshi K; Inoue T; Endo K; Sakahara H
Kaku Igaku; 1993 Apr; 30(4):441-7. PubMed ID: 8315895
[TBL] [Abstract][Full Text] [Related]
17. Characterization of CA 125 antigen identified by monoclonal antibodies that recognize different epitopes.
Kobayashi H; Ohi H; Moniwa N; Shinohara H; Terao T
Clin Biochem; 1993 Oct; 26(5):391-7. PubMed ID: 7507803
[TBL] [Abstract][Full Text] [Related]
18. CA125 antigen levels in obstetric and gynecologic patients.
Niloff JM; Knapp RC; Schaetzl E; Reynolds C; Bast RC
Obstet Gynecol; 1984 Nov; 64(5):703-7. PubMed ID: 6208522
[TBL] [Abstract][Full Text] [Related]
19. An immunoenzymometric assay for a CA125-like antigen, CA602.
Mochizuki H; Sato I; Nagoya K; Furusako S; Yamauchi T; Masuko H; Sato H; Morishita H; Yajima M; Sasaki H
J Clin Lab Anal; 1992; 6(2):84-90. PubMed ID: 1383480
[TBL] [Abstract][Full Text] [Related]
20. [Application of monoclonal antibody OC 125 in gynecological oncology].
Wu AR; Wang EY; Wang XX; Jia XH; Li L
Zhonghua Zhong Liu Za Zhi; 1988 Mar; 10(2):132-6. PubMed ID: 3208653
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]